Fibroblast activation protein ligands for targeted delivery applications
The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FA...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DAKHEL PLAZA, Sheila CAZZAMALLI, Samuele MILLUL, Jacopo SAMAIN, Florent BIANCOFIORE, Ilaria SCHMIDT, Eleonore DONCKELE, Etienne J |
description | The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021220663A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021220663A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021220663A13</originalsourceid><addsrcrecordid>eNqNy0EKwjAQQNFsXIh6hwHXQptC90UsPYCuyzSZloEhCZmh4O0F8QCu_ub9o5tGXmpeBNUAg_GOxjlBqdmIEwhvmKLCmisY1o2MIkQS3qm-AUsRDt9Dz-6woihdfj256_h43qcblTyTFgyUyObh5Rvfet_0fTe03X_qA93ZNe4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fibroblast activation protein ligands for targeted delivery applications</title><source>esp@cenet</source><creator>DAKHEL PLAZA, Sheila ; CAZZAMALLI, Samuele ; MILLUL, Jacopo ; SAMAIN, Florent ; BIANCOFIORE, Ilaria ; SCHMIDT, Eleonore ; DONCKELE, Etienne J</creator><creatorcontrib>DAKHEL PLAZA, Sheila ; CAZZAMALLI, Samuele ; MILLUL, Jacopo ; SAMAIN, Florent ; BIANCOFIORE, Ilaria ; SCHMIDT, Eleonore ; DONCKELE, Etienne J</creatorcontrib><description>The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221006&DB=EPODOC&CC=AU&NR=2021220663A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221006&DB=EPODOC&CC=AU&NR=2021220663A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAKHEL PLAZA, Sheila</creatorcontrib><creatorcontrib>CAZZAMALLI, Samuele</creatorcontrib><creatorcontrib>MILLUL, Jacopo</creatorcontrib><creatorcontrib>SAMAIN, Florent</creatorcontrib><creatorcontrib>BIANCOFIORE, Ilaria</creatorcontrib><creatorcontrib>SCHMIDT, Eleonore</creatorcontrib><creatorcontrib>DONCKELE, Etienne J</creatorcontrib><title>Fibroblast activation protein ligands for targeted delivery applications</title><description>The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNy0EKwjAQQNFsXIh6hwHXQptC90UsPYCuyzSZloEhCZmh4O0F8QCu_ub9o5tGXmpeBNUAg_GOxjlBqdmIEwhvmKLCmisY1o2MIkQS3qm-AUsRDt9Dz-6woihdfj256_h43qcblTyTFgyUyObh5Rvfet_0fTe03X_qA93ZNe4</recordid><startdate>20221006</startdate><enddate>20221006</enddate><creator>DAKHEL PLAZA, Sheila</creator><creator>CAZZAMALLI, Samuele</creator><creator>MILLUL, Jacopo</creator><creator>SAMAIN, Florent</creator><creator>BIANCOFIORE, Ilaria</creator><creator>SCHMIDT, Eleonore</creator><creator>DONCKELE, Etienne J</creator><scope>EVB</scope></search><sort><creationdate>20221006</creationdate><title>Fibroblast activation protein ligands for targeted delivery applications</title><author>DAKHEL PLAZA, Sheila ; CAZZAMALLI, Samuele ; MILLUL, Jacopo ; SAMAIN, Florent ; BIANCOFIORE, Ilaria ; SCHMIDT, Eleonore ; DONCKELE, Etienne J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021220663A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DAKHEL PLAZA, Sheila</creatorcontrib><creatorcontrib>CAZZAMALLI, Samuele</creatorcontrib><creatorcontrib>MILLUL, Jacopo</creatorcontrib><creatorcontrib>SAMAIN, Florent</creatorcontrib><creatorcontrib>BIANCOFIORE, Ilaria</creatorcontrib><creatorcontrib>SCHMIDT, Eleonore</creatorcontrib><creatorcontrib>DONCKELE, Etienne J</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAKHEL PLAZA, Sheila</au><au>CAZZAMALLI, Samuele</au><au>MILLUL, Jacopo</au><au>SAMAIN, Florent</au><au>BIANCOFIORE, Ilaria</au><au>SCHMIDT, Eleonore</au><au>DONCKELE, Etienne J</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fibroblast activation protein ligands for targeted delivery applications</title><date>2022-10-06</date><risdate>2022</risdate><abstract>The present invention relates to ligands of Fibroblast Activation Protein (FAP) for the active delivery of various payloads (e.g. cytotoxic drugs, radionuclides, fluorophores, proteins and immunomodulators) at the site of disease. In particular, the present invention relates to the development of FAP ligands for targeting applications, in particular diagnostic methods and/or methods for therapy or surgery in relation to a disease or disorder, such as cancer, inflammation or another disease characterized by overexpression of FAP.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2021220663A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Fibroblast activation protein ligands for targeted delivery applications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T22%3A41%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAKHEL%20PLAZA,%20Sheila&rft.date=2022-10-06&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021220663A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |